M2 AML
You don't need to be Editor-In-Chief to add or edit content to WikiDoc. You can begin to add to or edit text on this WikiDoc page by clicking on the edit button at the top of this page. Next enter or edit the information that you would like to appear here. Once you are done editing, scroll down and click the Save page button at the bottom of the page.
| M2 AML Classification and external resources | |
| ICD-O: | 9874/3 |
|---|---|
|
WikiDoc Resources for M2 AML | |
|
Articles | |
|---|---|
|
Media | |
|
Evidence Based Medicine | |
|
Clinical Trials | |
|
Ongoing Trials on M2 AML at Clinical Trials.gov Clinical Trials on M2 AML at Google
| |
|
Guidelines / Policies / Govt | |
|
US National Guidelines Clearinghouse on M2 AML
| |
|
Books | |
|
News | |
|
Commentary | |
|
Definitions | |
|
Patient Resources / Community | |
|
Directions to Hospitals Treating M2 AML Risk calculators and risk factors for M2 AML
| |
|
Healthcare Provider Resources | |
|
Continuing Medical Education (CME) | |
|
International | |
|
| |
|
Businness | |
|
Experimental / Informatics | |
Please Take Over This Page and Apply to be Editor-In-Chief for this topic: There can be one or more than one Editor-In-Chief. You may also apply to be an Associate Editor-In-Chief of one of the subtopics below. Please mail us [1] to indicate your interest in serving either as an Editor-In-Chief of the entire topic or as an Associate Editor-In-Chief for a subtopic. Please be sure to attach your CV and or biographical sketch.
Overview
M2 is a subtype of AML (Acute Myeloid Leukemia). This subtypeis characterized by a translocation of a part of chromosome 8 to chromosome 21, written as t(8;21). On both sides of the chromosome, now containing pieces from two chromosomes, the DNA codes for different proteins. These two proteins are now being created as one single large protein, with a different effect in the body as the two proteins originally coded by the two different chromosomes. The two different proteins that are fused together are:
- RUNX1
- ETO
References
- Nature Reviews: Cancer
WikiDoc Research Resources for M2 AML | |
|---|---|
| Articles on M2 AML | Most recent articles on M2 AML • Most cited articles on M2 AML • Review articles on M2 AML • Articles on M2 AML in N Eng J Med, Lancet, BMJ |
| Media (Slides, Video, Images, MP3) on M2 AML | Powerpoint slides on M2 AML • Images of M2 AML • Photos of M2 AML • Podcasts & MP3s on M2 AML • Videos on M2 AML |
| Evidence Based Medicine Regarding M2 AML | Cochrane Collaboration on M2 AML • Bandolier on M2 AML • TRIP on M2 AML |
| Cost Effectiveness of M2 AML | Cost Effectiveness of M2 AML |
| Clinical Trials Involving M2 AML | Ongoing Trials on M2 AML at Clinical Trials.gov • Trial results on M2 AML • Clinical Trials on M2 AML at Google |
| Guidelines / Policies / Government Resources (FDA/CDC) Regarding M2 AML | US National Guidelines Clearinghouse on M2 AML • NICE Guidance on M2 AML • NHS PRODIGY Guidance • FDA on M2 AML • CDC on M2 AML |
| Textbook Information on M2 AML | Books and Textbook Information on M2 AML |
| Pharmacology Resources on M2 AML | Dosing of M2 AML • Drug interactions with M2 AML • Side effects of M2 AML • Allergic reactions to M2 AML • Overdose information on M2 AML • Carcinogenicity information on M2 AML • M2 AML in pregnancy • Pharmacokinetics of M2 AML • |
| Genetics, Pharmacogenomics, and Proteinomics of M2 AML | Genetics of M2 AML • Pharmacogenomics of M2 AML • Proteomics of M2 AML |
| Newstories on M2 AML | M2 AML in the news • Be alerted to news on M2 AML • News trends on M2 AML |
| Commentary on M2 AML | Blogs on M2 AML |
| Patient Resources on M2 AML | Patient resources on M2 AML • Discussion groups on M2 AML • Patient Handouts on M2 AML • Directions to Hospitals Treating M2 AML • Risk calculators and risk factors for M2 AML |
| Healthcare Provider Resources on M2 AML | Symptoms of M2 AML • Causes & Risk Factors for M2 AML • Diagnostic studies for M2 AML • Treatment of M2 AML |
| Continuing Medical Education (CME) Programs on M2 AML | CME Programs on M2 AML |
| International Resources on M2 AML | M2 AML en Espanol • M2 AML en Francais |
| Business Resources on M2 AML | M2 AML in the Marketplace • Patents on M2 AML |
| Informatics Resources on M2 AML | List of terms related to M2 AML |
| ||||
Acknowledgement and Attribution Regarding Sources of Content
Some of the initial content on this page may be incorporated in part from copyleft sources in the public domain including wikis such as Wikipedia and AskDrWiki. Drug information for patients came from the The National Library of Medicine. Infectious disease information may have come from the Centers for Disease Control (CDC). Differential Diagnoses are drawn from clinicians as well as an amalgamation of 3 sources: 1.The Disease Database; 2. Kahan, Scott, Smith, Ellen G. In A Page: Signs and Symptoms. Malden, Massachusetts: Blackwell Publishing, 2004:3; 3. Sailer, Christian, Wasner, Susanne. Differential Diagnosis Pocket. Hermosa Beach, CA: Borm Bruckmeir Publishing LLC, 2002:7 .

